| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 13 | 2020 | 5098 | 0.780 |
Why?
|
| Carcinoma, Ductal | 1 | 2016 | 145 | 0.500 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2008 | 668 | 0.470 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 677 | 0.430 |
Why?
|
| Protein Kinase C | 3 | 2008 | 396 | 0.410 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 52 | 0.400 |
Why?
|
| Isoenzymes | 3 | 2008 | 608 | 0.390 |
Why?
|
| Carcinoma, Pancreatic Ductal | 7 | 2019 | 1754 | 0.380 |
Why?
|
| Lymphocyte Activation | 5 | 2020 | 1681 | 0.380 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2011 | 365 | 0.360 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 974 | 0.360 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 1123 | 0.360 |
Why?
|
| Metabolomics | 1 | 2013 | 479 | 0.350 |
Why?
|
| Tretinoin | 1 | 2011 | 623 | 0.330 |
Why?
|
| Interleukin-17 | 2 | 2020 | 253 | 0.300 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 1438 | 0.210 |
Why?
|
| 5-Methylcytosine | 2 | 2019 | 55 | 0.190 |
Why?
|
| Signal Transduction | 5 | 2020 | 11978 | 0.190 |
Why?
|
| Extracellular Traps | 1 | 2020 | 25 | 0.190 |
Why?
|
| Lactic Acid | 2 | 2019 | 306 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2019 | 50 | 0.170 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 327 | 0.170 |
Why?
|
| Mitochondrial Dynamics | 1 | 2019 | 63 | 0.170 |
Why?
|
| Isoquinolines | 1 | 2019 | 116 | 0.170 |
Why?
|
| Radiation-Protective Agents | 1 | 2019 | 128 | 0.160 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2018 | 44 | 0.160 |
Why?
|
| Chromogranins | 1 | 2018 | 85 | 0.160 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2019 | 107 | 0.160 |
Why?
|
| Curcumin | 2 | 2016 | 117 | 0.160 |
Why?
|
| Adenocarcinoma in Situ | 1 | 2018 | 31 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 8891 | 0.160 |
Why?
|
| Animals | 18 | 2020 | 59534 | 0.150 |
Why?
|
| Calcineurin | 2 | 2008 | 133 | 0.150 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2018 | 108 | 0.150 |
Why?
|
| Tumor Microenvironment | 3 | 2020 | 2868 | 0.150 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 194 | 0.150 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 1397 | 0.150 |
Why?
|
| Glycine | 1 | 2019 | 289 | 0.150 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 218 | 0.150 |
Why?
|
| Gene Editing | 1 | 2019 | 217 | 0.140 |
Why?
|
| Recombination, Genetic | 1 | 2019 | 612 | 0.140 |
Why?
|
| Oncogenes | 1 | 2019 | 672 | 0.140 |
Why?
|
| Mice | 14 | 2019 | 34438 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 745 | 0.130 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 1340 | 0.130 |
Why?
|
| Protein Kinase C-theta | 3 | 2008 | 11 | 0.120 |
Why?
|
| Biomarkers, Tumor | 2 | 2020 | 10356 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 650 | 0.120 |
Why?
|
| Neoplasms | 3 | 2016 | 15204 | 0.120 |
Why?
|
| Forkhead Transcription Factors | 2 | 2008 | 775 | 0.120 |
Why?
|
| Mitochondria | 2 | 2019 | 1284 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2008 | 1144 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 459 | 0.110 |
Why?
|
| Exosomes | 1 | 2016 | 256 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2018 | 1151 | 0.110 |
Why?
|
| Single-Cell Analysis | 1 | 2015 | 471 | 0.100 |
Why?
|
| Cell Line, Tumor | 8 | 2020 | 14590 | 0.100 |
Why?
|
| Triazoles | 1 | 2016 | 620 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2008 | 1035 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2019 | 1826 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 811 | 0.100 |
Why?
|
| Radiation Injuries | 1 | 2019 | 1412 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 702 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 625 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2019 | 5680 | 0.090 |
Why?
|
| Metabolome | 1 | 2013 | 343 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 3831 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1447 | 0.090 |
Why?
|
| Glucose | 1 | 2016 | 1246 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2019 | 7245 | 0.090 |
Why?
|
| bcl-X Protein | 2 | 2008 | 196 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1166 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2016 | 1653 | 0.090 |
Why?
|
| Computational Biology | 1 | 2015 | 1271 | 0.090 |
Why?
|
| Cell Adhesion | 1 | 2011 | 1003 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 725 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 5188 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2019 | 5258 | 0.080 |
Why?
|
| NFATC Transcription Factors | 1 | 2008 | 99 | 0.080 |
Why?
|
| Apoptosis | 5 | 2019 | 7607 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1223 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2012 | 556 | 0.080 |
Why?
|
| Cell Survival | 3 | 2008 | 3047 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2012 | 4318 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2008 | 294 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2020 | 1588 | 0.070 |
Why?
|
| Complementarity Determining Regions | 1 | 2006 | 43 | 0.070 |
Why?
|
| Graves Disease | 1 | 2006 | 50 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2019 | 2671 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 3083 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 601 | 0.070 |
Why?
|
| Oxidative Phosphorylation | 2 | 2019 | 254 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2008 | 402 | 0.070 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2006 | 247 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2011 | 3537 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 2504 | 0.060 |
Why?
|
| Cell Communication | 1 | 2008 | 505 | 0.060 |
Why?
|
| Doxorubicin | 1 | 2012 | 3005 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 6916 | 0.060 |
Why?
|
| Humans | 16 | 2020 | 262210 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 5387 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 5157 | 0.060 |
Why?
|
| Cell Movement | 1 | 2011 | 2465 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2019 | 1504 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2006 | 580 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2011 | 6132 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 14301 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 1267 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 4140 | 0.050 |
Why?
|
| Ketoglutaric Acids | 1 | 2019 | 38 | 0.040 |
Why?
|
| Wnt-5a Protein | 1 | 2019 | 45 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2006 | 2449 | 0.040 |
Why?
|
| Dynamins | 1 | 2019 | 75 | 0.040 |
Why?
|
| Quinazolinones | 1 | 2019 | 51 | 0.040 |
Why?
|
| Disease Progression | 3 | 2018 | 6695 | 0.040 |
Why?
|
| Cytokines | 1 | 2008 | 2811 | 0.040 |
Why?
|
| Mutation | 1 | 2018 | 15194 | 0.040 |
Why?
|
| Octamer Transcription Factors | 1 | 2018 | 18 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2006 | 2087 | 0.040 |
Why?
|
| Dependovirus | 1 | 2019 | 136 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 97 | 0.040 |
Why?
|
| Retinal Dehydrogenase | 1 | 2018 | 91 | 0.040 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2018 | 103 | 0.040 |
Why?
|
| Patient-Specific Modeling | 1 | 2017 | 28 | 0.040 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 269 | 0.040 |
Why?
|
| Pancreatitis, Chronic | 1 | 2018 | 117 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 339 | 0.040 |
Why?
|
| Click Chemistry | 1 | 2016 | 9 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2016 | 1494 | 0.030 |
Why?
|
| Neutrophils | 1 | 2020 | 834 | 0.030 |
Why?
|
| Fermentation | 1 | 2016 | 60 | 0.030 |
Why?
|
| Half-Life | 1 | 2016 | 259 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 132 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2016 | 194 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 715 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2019 | 819 | 0.030 |
Why?
|
| Lentivirus | 1 | 2016 | 169 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2016 | 366 | 0.030 |
Why?
|
| Cell Shape | 1 | 2015 | 129 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2016 | 274 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 278 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 506 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2016 | 566 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 1518 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 1050 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 394 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 547 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 3861 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2019 | 1688 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 768 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 523 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 496 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 1879 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3987 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2018 | 3024 | 0.020 |
Why?
|
| Transcriptome | 1 | 2019 | 1860 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 2078 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2018 | 2234 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 705 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2362 | 0.020 |
Why?
|
| Histones | 1 | 2017 | 1467 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 2214 | 0.020 |
Why?
|
| Glutathione | 1 | 2012 | 366 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2016 | 1031 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 3443 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 2054 | 0.020 |
Why?
|
| NF-kappa B | 2 | 2006 | 1551 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 2266 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2062 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 1955 | 0.020 |
Why?
|
| Interleukin-7 | 1 | 2008 | 95 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2008 | 170 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2008 | 170 | 0.020 |
Why?
|
| Prostatic Neoplasms | 2 | 2016 | 5777 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 3250 | 0.020 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2006 | 9 | 0.020 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2006 | 38 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 3553 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2006 | 117 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2008 | 185 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 622 | 0.020 |
Why?
|
| Thyroxine | 1 | 2006 | 116 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 7226 | 0.020 |
Why?
|
| Male | 4 | 2019 | 123277 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12236 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2006 | 266 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2006 | 311 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 5121 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 6036 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2006 | 244 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2006 | 256 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 469 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2006 | 250 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 798 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 662 | 0.010 |
Why?
|
| Female | 3 | 2019 | 142240 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 15708 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2012 | 2150 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 3190 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 5088 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 2485 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 5606 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 7792 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 21474 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 29997 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 70322 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 78087 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 86445 | 0.010 |
Why?
|